Video Experimental Relacionado
Updated: Jul 18, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
La industria farmacéutica como un actor político
1Centre for Research in Health and Medicine, University of Sussex, BN1 9SN, Brighton, UK. j.w.abraham@sussex.ac.uk
Lancet (London, England)
|November 16, 2002
Resumen
La regulación de la industria farmacéutica debe equilibrar los beneficios con la protección de la salud pública. Este estudio examina la influencia de la industria en la regulación de medicamentos y sugiere métodos para fortalecer la supervisión de medicamentos más seguros.
Área de la Ciencia:
- La política farmacéutica en el ámbito de la salud
- La ciencia reguladora es una ciencia reguladora.
- Salud pública La salud pública.
Sus antecedentes:
- La industria farmacéutica proporciona medicamentos esenciales, lo que requiere marcos políticos para la gobernanza.
- Una regulación sólida es crucial para salvaguardar la salud pública de medicamentos inseguros, ineficaces o innecesarios.
- Los sistemas actuales de regulación de medicamentos pueden verse comprometidos por la influencia de la industria, lo que podría perjudicar el interés público.
Objetivo del estudio:
- Analizar el alcance de la influencia de la industria farmacéutica en los procesos regulatorios de medicamentos.
- Identificar los mecanismos a través de los cuales la industria impacta a los organismos gubernamentales y regulatorios.
- Proponer estrategias para mitigar la influencia indebida de la industria y mejorar la solidez regulatoria.
Principales métodos:
- Discusión de varios métodos empleados por la industria farmacéutica para influir en las agencias reguladoras.
- Análisis de los factores políticos y económicos que permiten la influencia de la industria.
- Revisión de los marcos regulatorios existentes y sus vulnerabilidades.
Principales resultados:
- La industria farmacéutica ejerce una influencia significativa en la regulación de los medicamentos a través de diversos canales.
- Esta influencia puede comprometer potencialmente la objetividad y la eficacia de la supervisión regulatoria.
- Es posible que los sistemas regulatorios existentes no protejan adecuadamente la salud pública de las presiones de la industria.
Conclusiones:
- Es esencial fortalecer los marcos políticos que rigen la industria farmacéutica.
- Las medidas de implementación para frenar la influencia de la industria son necesarias para una regulación robusta de las drogas.
- La supervisión reforzada es vital para garantizar la seguridad, la eficacia y la necesidad de los productos farmacéuticos para el beneficio público.
Videos de Conceptos Relacionados
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.